Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05240651 · ClinicalTrials.gov registry record
Change in Stroke Volume Index After Diuresis for Patients With Decompensated Heart Failure
A clinical trial of Acute Decompensated Heart Failure, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT05240651 is a study of Acute Decompensated Heart Failure that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 50 participants, below the 455-participant average among 12 other Acute Decompensated Heart Failure trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05240651, a study of Acute Decompensated Heart Failure, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective cohort study for 50 patients admitted to the cardiac care unit requiring clinically-indicated diuretic therapy for congestive heart failure. The purpose of this study is to assess the role of non-invasive cardiac output monitoring (NICOM) with the Starling Fluid Management System (Baxter Medical, Deerfield, IL) in determining volume status in patients with acute decompensated heart failure requiring intravenous diuretic therapy.
Conditions Studied
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-08-30 |
| Est. Completion | 2026-07-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05240651
The ClinicalTrials.gov registry entry for NCT05240651 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 455-participant average among 12 other Acute Decompensated Heart Failure trials with a reported enrollment target (89% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Decompensated Heart Failure appearing as the primary indexed condition, and to 0 interventions.
NCT05240651 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05240651 about?
NCT05240651 is a clinical study titled "Change in Stroke Volume Index After Diuresis for Patients With Decompensated Heart Failure". This is a prospective cohort study for 50 patients admitted to the cardiac care unit requiring clinically-indicated diuretic therapy for congestive heart failure. The purpose of this study is to assess the role of non-invasive cardiac output monitoring (NICOM) with the Starling Fluid Management Syst...
What is the current status of trial NCT05240651?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2022-08-30. Estimated completion is 2026-07-01.
What conditions does trial NCT05240651 study?
This clinical trial studies the following conditions: Acute Decompensated Heart Failure.
Who is sponsoring clinical trial NCT05240651?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05240651 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Decompensated Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)
RECRUITING · Phase 3
-
Low Level Tragus Stimulation in Acute Decompensated Heart Failure
RECRUITING · NA
-
IC14 for Treatment of Acute Decompensated Heart Failure
ACTIVE NOT RECRUITING · Phase 1
-
DORAYA-HF Early Feasibility Study
ACTIVE NOT RECRUITING · NA
-
Use of the Impella BTR™ in Patients With Heart Failure: An Early Feasibility Study
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.